This is a draft version - Page is not published

Financing, Equity Capital Markets

Point Biopharmaa Inc.

09/22
|
$139.4 Million
Piper Sandler served as bookrunner for POINT Biopharmaa Global, Inc. on its follow on offering
Sub-Type
CMFO
Sub-Sector
Biopharma